# National Institute for Health Research, United Kingdom

Organization · id `cardio:org-national-institute-for-health-research-united-kingdom` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov sponsor names](<https://clinicaltrials.gov/search?spons=National+Institute+for+Health+Research%2C+United+Kingdom>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 7 trials in this atlas.

## Technical summary

Sponsor class other government. No ROR record matches the name exactly.

## The registry's words

- Sponsor name: National Institute for Health Research, United Kingdom
- Sponsor class: OTHER\_GOV

## Connected pages

- Sponsors: AARDVARK (Aortic Aneurysmal Regression of Dilation: Value of ACE-Inhibition on RisK) (`cardio:ct-nct01118520`)
- Sponsors: Optimised Pacing Program (`cardio:ct-nct01819662`)
- Sponsors: Study of Efficacy and Safety of Percutaneous Coronary Intervention to Improve Survival in Heart Failure (`cardio:ct-nct01920048`)
- Sponsors: A Trial of Low-dose Adjunctive alTeplase During prIMary PCI (`cardio:ct-nct02257294`)
- Sponsors: The Efficacy and Safety of Pirfenidone in Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction (`cardio:ct-nct02932566`)
- Sponsors: The Efficacy and Mechanism of Trientine in Patients With Hypertrophic Cardiomyopathy (`cardio:ct-nct04706429`)
- Sponsors: GEKO Venous Thromboembolism Prevention Study (`cardio:ct-nct05476913`)

## Provenance

Content hash: 6f7dad4c5029ba98eff5ad2608864883274ec68b7acd23f0be810ea7544ed132
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
